Tuesday, January 2, 2024

New year, new chance to impact millions affected by diabetes

It takes all of us to end diabetes. Join us in the fight.
View in browser

American Diabetes Logo

Let’s Do More in 2024!

With your help, we made great progress in 2023, but the fight to end diabetes isn’t over. Start the new year with a renewed purpose to impact the lives of millions.

This year, our resolution is to get closer to a cure to end diabetes.

Dear Friend,

It’s a new year and new opportunity for you to join the American Diabetes Association® (ADA) in the fight to end diabetes. Your critical donation can improve the lives of the over 136 million Americans living with diabetes or prediabetes by helping support critical research, education, and advocacy.

As a small token to show our gratitude for your unwavering commitment to our mission, we hope you’ll enjoy this special message from the ADA’s CEO,
Charles “Chuck” Henderson.

Video: Charles "Chuck" Henderson

With your help, we made several accomplishments in 2023, including:

  • Achieved an insulin copay cap of $35 per month for people on Medicare as well as passed bills to cap insulin copays for state-regulated health insurance plans

  • Hosted over 11,000 attendees to our annual diabetes education conference, the Scientific Sessions

  • Welcomed nearly 2,000 children with diabetes to ADA camps across the U.S.

  • And so much more!

Donate Today Button

Friend, although we made tremendous strides in 2023, the fight isn’t over. We need your help to do more in 2024 to stretch our impact even further. That’s why we’re calling on you to stand with us in the fight and continue to make a difference in the lives of millions impacted by diabetes through your donation.

Image: It Takes All of Us To End Diabetes
 
Donate Now Button
 

Facebook Twitter Instagram youTube LinkedIn
© 2024 American Diabetes Association®. All rights reserved.

askada@diabetes.org  |   1‑800‑342-2383

Learn more at diabetes.org.
Forward to a Friend  |   Manage Your Communications  |   Unsubscribe
 
 

No comments:

Post a Comment